Skip to main content
Premium Trial:

Request an Annual Quote

James Kramer, Cyndi Tolman

Premium

Serologicals has hired James Kramer as vice president of global manufacturing operations, and has appointed Cyndi Tolman managing director of plasma operations, the company said last week.

Kramer will report directly to David Dodd, president and CEO. He will be responsible for the production and supply chain related to plasma operations and the manufacturing operations in Kankakee, Ill.; Toronto; Milford, Mass.; Gaithersburg, Md.; and Livingston, UK. Previously, Kramer was vice president of plasma operations.

Tolman, who reports directly to Kramer, will be responsible for all activities within plasma operations. She joined Serologicals in 1990 as executive director of the Columbia, SC, donor center.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more